HEDMAN THOMAS P has a total of 13 patent applications. Its first patent ever was published in 2002. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, medical technology and foods and drinks are SENJU USA INC, EYEPOINT PHARMACEUTICALS US INC and FORSIGHT VISION5 INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | WIPO (World Intellectual Property Organization) | 3 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Implantable devices | |
#4 | Syringes | |
#5 | Enzymes | |
#6 | Object sterilising |
# | Name | Total Patents |
---|---|---|
#1 | Hedman Thomas P | 13 |
#2 | Slusarewicz Paul | 5 |
#3 | Slusarewicz Pawel | 1 |
Publication | Filing date | Title |
---|---|---|
WO2012006095A1 | Tissue crosslinking for treatment of snoring and obstructive sleep apnea | |
US2013085569A1 | Crosslinker enhanced repair of knee meniscus | |
US2010041616A1 | Formulations for nonsurgical exogenous crosslink therapy | |
US2008064021A1 | Direct application of non-toxic crosslinking reagents to resist progressive spinal degeneration and deformity | |
US2007202143A1 | Direct application of non-toxic crosslinking reagents to restabilize surgically destabilized intervertebral joints | |
US2007183973A1 | Direct application of non-toxic crosslinking reagents to resist progressive spinal deformity |